Skip to Page Content

FREE PREVIEW | Subscribers get full access to this article:   Free Trial »   Subscribe »

Start-Up

2C Tech Corp. Inc.

Preserving retinal cells with injectable nanoparticles


Executive Summary

2C Tech Corp. is developing a non-surgical, nanotechnology-based artificial retinal prostheses designed to overcome the limitations of current, implanted silicon chips and to operate at the cellular level over the entire retina to preserve sight. The start-up’s injectable SeeQ device converts ambient light to electrical energy. As photoreceptors are stimulated by the electrical charge, they release growth factors beneficial for retinal cell preservation.


Purchase this Article

$85.00   Buy Now


For $85.00, purchase this 1836-word article and receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.

Log In


Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.